Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of HS-10360 in Healthy Subjects.

NCT04986436 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HS-10360
DRUG: Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.